Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and velpatasvir in pregnant women with hepatitis C
ACTRN12619000054112Phase 4Terminated
- Sponsor
- Monash Health
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sofosbuvir and velpatasvir in hepatitis C virus infection, sponsored by Monash Health. Primary endpoints: Sofosbuvir metabolite pharmacokinetics and Velpatasvir pharmacokinetics. Started Feb 2020; status: terminated.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ACTRN12619000054112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000054112.